Marksans Pharma Ltd. — AGM Information 2025

Aug 8, 2025

==> picture [47 x 46] intentionally omitted <==

==> picture [86 x 18] intentionally omitted <==

==> picture [111 x 18] intentionally omitted <==

Date : August 8, 2025

BSE Limited National Stock Exchange of India Limited Corporate Relation Department Listing Department Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block-G, Dalal Street, Bandra-Kurla Complex, Mumbai – 400001. Bandra (East), Mumbai – 400051. Scrip Code: 524404 Symbol: MARKSANS

Dear Sir/Madam,

Sub: Proceedings of the 33[rd] AGM of Marksans Pharma Limited

Pursuant to Regulation 30 read with Part-A of Schedule-III of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, kindly find enclosed herewith proceedings of the 33[rd] Annual General Meeting of Marksans Pharma Limited held today i.e. Friday, August 8, 2025 at 09:00 A.M. through Video Conferencing /Other Audio Visual means deemed to be at the registered office of the Company situated at 11[th] Floor, Grandeur, Veera Desai Extension Road, Oshiwara, Andheri (W), Mumbai, India.

We request you to take the aforesaid on records.

Thanking You.

Yours faithfully, For Marksans Pharma Limited

Digitally signed H by H PANIGRAHI PANIGRAHI Date: 2025.08.08 17:17:37 +05'30'

Harshavardhan Panigrahi Company Secretary

Encl: As Above

==> picture [5 x 74] intentionally omitted <==

==> picture [72 x 16] intentionally omitted <==

==> picture [93 x 16] intentionally omitted <==

==> picture [431 x 33] intentionally omitted <==

==> picture [47 x 46] intentionally omitted <==

==> picture [86 x 18] intentionally omitted <==

==> picture [111 x 18] intentionally omitted <==

Summary of proceedings of the 33[rd] Annual General Meeting of Marksans Pharma Limited held on Friday, August 8, 2025 at 09:00 A.M. through Video Conferencing / Other Audio Visual means (VC)

This is to inform you that the 33[rd] Annual General Meeting (“AGM”) of Marksans Pharma Limited (“the Company”) was held today i.e. Friday, August 8, 2025 at 09:00 A.M. through VC and the businesses mentioned in the Notice dated July 11, 2025 read along with Addendum dated July 25, 2025 were transacted.

1. Date, Time and Venue of the Meeting:

The AGM of the Members of the Company was held on Friday, August 8, 2025 at 09:00 A.M. through Video Conferencing / Other Audio Visual means (VC). For the purpose of recording the proceedings, the AGM was deemed to have been held at the registered office of the Company at 11[th] Floor, Grandeur, Veera Desai Extension Road, Oshiwara, Andheri (W), Mumbai, India.

2. Brief details of the items deliberated at the meeting and the results thereof:

• a. Mr. Mark Saldanha, Chairman chaired the proceedings of the meeting.

• b. Mr. Harshavardhan Panigrahi, Company Secretary explained the procedure for conducting the meeting through VC as well as voting during the AGM.

• c. The Chairman informed that, all the Directors of the Company & Mr. Jitendra Sharma - Chief Financial Officer had joined the meeting from their respective locations. The Chairman further informed that Mr. Digant Mahesh Parikh - Chairman of the Audit Committee and Mr. Abhinna Sundar Mohanty - Chairman of the Stakeholder Relationship Committee and the Nomination and Remuneration Committee attended the AGM from their respective locations. The Chairman further informed that authorized representative of Statutory Auditor, Secretarial Auditor cum Scrutinizer had also joined the meeting from their respective locations.

• d. The requisite quorum being present, the Chairman called the meeting in order.

• e. The Chairman informed that the meeting was being held through VC in accordance with the provisions of Companies Act, 2013, circulars issued by the Ministry of Corporate Affairs and SEBI.

• f. With the consent of the members, the Notice convening the 33[rd] AGM and Addendum thereto and the Auditor's Reports were taken as read.

• g. The Chairman then delivered his speech.

• h. The Company Secretary informed the members that the Board had appointed Mr. Jinesh Dedhia, Practicing Company Secretary, to act as the Scrutinizer for the remote e-voting process and for its completion in a fair and transparent manner and to provide a consolidated report thereof.

==> picture [5 x 74] intentionally omitted <==

==> picture [72 x 16] intentionally omitted <==

==> picture [93 x 16] intentionally omitted <==

==> picture [431 x 33] intentionally omitted <==

==> picture [47 x 46] intentionally omitted <==

==> picture [86 x 18] intentionally omitted <==

==> picture [111 x 18] intentionally omitted <==

• i. The Company Secretary further informed that members who did not vote earlier through remote e-voting might vote electronically during the course of the meeting.

• j. The Company Secretary then called the names of those members who had registered themselves to speak or ask questions pertaining to the performance of the Company during the Financial Year 2024-25, one by one.

• k. Clarifications were provided by the Chairman to the queries raised by the members at the meeting.

• l. The Company Secretary informed that results of voting would be announced on or before August 9, 2025 by intimation to the Stock Exchanges and would also be placed on the website of the Company www.marksanspharma.com.

• m. The Chairman then thanked the Members for their co-operation and declared that the Meeting be concluded.

• n. The following items of Ordinary and Special businesses as per the Notice of AGM dated July 11 2025, read along with addendum dated July 25, 2025 were transacted through remote e-voting and through e-voting during the AGM:

Ordinary Business

• To receive, consider and adopt:

• a) the Audited Standalone Financial Statements of the Company for the Financial Year ended March 31, 2025, comprising of Standalone Balance Sheet as at March 31, 2025, Standalone Statement of Profit & Loss and Standalone Cash Flow Statement for the Financial Year April 1, 2024 to March 31, 2025 including its Schedules and the Notes attached thereto and forming part thereof along with the reports of the Board of Directors and the Statutory Auditors thereon; and

• b) the Audited Consolidated Financial Statements of the Company for the Financial Year ended March 31, 2025, comprising of Consolidated Balance Sheet as at March 31, 2025, Consolidated Statement of Profit & Loss and Consolidated Cash Flow Statement for the Financial Year April 1, 2024 to March 31, 2025 including its Schedules and the Notes attached thereto and forming part thereof along with the reports of the Statutory Auditors thereon.

• To declare dividend on equity shares recommended by the Board of Directors at its meeting held on May 19, 2025. The Board of Directors recommended equity dividend of Rs. 0.80 (80%) per equity share of Re. 1/- each face value.

• To appoint a director in place of Mrs. Sandra Saldana (DIN: 00021023) who retires by rotation and being eligible offered herself for re-appointment.

==> picture [5 x 74] intentionally omitted <==

==> picture [72 x 16] intentionally omitted <==

==> picture [93 x 16] intentionally omitted <==

==> picture [431 x 33] intentionally omitted <==

==> picture [47 x 46] intentionally omitted <==

==> picture [86 x 18] intentionally omitted <==

==> picture [111 x 18] intentionally omitted <==

Special Business

• To approve appointment of Mr. Srinivas Mishra (DIN: 00007995) as an Independent Director of the Company for a period of five (5) consecutive years with effect from April 1, 2025.

• To approve appointment of M/s Jinesh Dedhia & Associates as secretarial auditor for a term of five (5) years.

• To approve Amendment to Marksans Employees Stock Option Scheme 2024.

• To approve grant of employee stock options to the eligible employees of the subsidiary company(ies) of the Company under Marksans Employees Stock Option Scheme 2024.

• To approve re-appointment of and remuneration payable to Mr. Mark Saldanha (DIN: 00020983) as the Managing Director of the Company for a period of five (5) years with effect from October 06, 2025.

3. Manner of approval:

• Pursuant to the provisions of the Companies Act, 2013 and Regulation 44 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, the Company provided remote e-voting facility to its members to cast their votes electronically, on all the resolutions as set out above.

• Further, the facility for remote e-voting was also made available during the AGM to the members who were present at the AGM and had not cast their votes by remote e-voting earlier.

The Chairman thanked the Members and the Board of Directors for participating in the AGM and the AGM was concluded at 09:40 a.m. (IST).

Thereafter, the voting process was concluded, and all the resolutions were approved by the members with requisite majority.

Yours faithfully,

For Marksans Pharma Limited

==> picture [5 x 74] intentionally omitted <==

Digitally signed by H H PANIGRAHI PANIGRAHI Date: 2025.08.08 17:18:27 +05'30'

PANIGRAHI Harshavardhan Panigrahi Company Secretary

==> picture [72 x 16] intentionally omitted <==

==> picture [93 x 16] intentionally omitted <==

==> picture [431 x 33] intentionally omitted <==